What is ClearPoint Neuro's allowance for doubtful accounts?

ClearPoint Neuro (CLPT) reported allowance for doubtful accounts of $1.1M in Q1 2026.

How has ClearPoint Neuro's allowance for doubtful accounts changed year-over-year?

ClearPoint Neuro's allowance for doubtful accounts decreased by 15.4% year-over-year, from $1.3M to $1.1M.

What is the long-term trend for ClearPoint Neuro's allowance for doubtful accounts?

Over 5 years (2020 to 2025), ClearPoint Neuro's allowance for doubtful accounts has grown at a 82.1% compound annual growth rate (CAGR), from $60K to $1.2M.

ClearPoint Neuro CLPT Allowance for Doubtful Accounts

Allowance for Doubtful Accounts at other companies

AbbottABT

——

Boston ScientificBSX

——

IAR

Integra LifeSciencesIART

——

MedtronicMDT

——

PenumbraPEN

——

ITG

Integer HoldingsITGR

——

Other financials

Income statement

See full

Revenue$12.1M+42.9%

Gross profit$7.8M+51.1%

Operating income-$8.5M-37.6%

Net income-$9.6M-58.5%

EPS (diluted)-$0.32-45.5%

Balance sheet

See full

Cash & equivalents$36.5M+195%

Total debt$63.6M+1,750%

Total equity$18.8M-5.7%

Total assets$93.4M+211%

Cash flow

See full

Operating cash flow-$8.0M-29.1%

CapEx$645.0K+252%

Free cash flow-$8.6M-35.5%

Valuation

See full

Market cap$538.61M+69.2%

Enterprise value$565.68M+82.9%

P/S13.3×+3.4×

Profitability

See full

Gross margin62.3%+1.1pp

Operating margin-65.2%-1.9pp

Net margin-71.6%+8.8pp

FCF margin-65.7%+269pp

Returns & leverage

See full

Return on equity-149.7%+4,074pp

Debt / equity3.4×+3.2×

Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ClearPoint Neuro's allowance for doubtful accounts?: ClearPoint Neuro (CLPT) reported allowance for doubtful accounts of $1.1M in Q1 2026.
How has ClearPoint Neuro's allowance for doubtful accounts changed year-over-year?: ClearPoint Neuro's allowance for doubtful accounts decreased by 15.4% year-over-year, from $1.3M to $1.1M.
What is the long-term trend for ClearPoint Neuro's allowance for doubtful accounts?: Over 5 years (2020 to 2025), ClearPoint Neuro's allowance for doubtful accounts has grown at a 82.1% compound annual growth rate (CAGR), from $60K to $1.2M.